Circulating tumor DNA could have impact on risk assessment and personalizing adjuvant therapy in localized colon cancer

被引：0
|
作者：
Elbaiomy, M. [1 ]
Sabry, M. [2 ]
机构：
[1] Mansoura Univ, Oncol Ctr, Mansoura, Egypt
[2] Fac Med, Mansoura, Egypt
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.064
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-8
引用
收藏
页码：S16 / S16
页数：1
相关论文
共 50 条
  • [21] Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer
    Lee, B.
    Lipton, L.
    Cohen, J.
    Tie, J.
    Javed, A. A.
    Li, L.
    Goldstein, D.
    Burge, M.
    Cooray, P.
    Nagrial, A.
    Tebbutt, N. C.
    Thomson, B.
    Nikfarjam, M.
    Harris, M.
    Haydon, A.
    Lawrence, B.
    Tai, D. W. M.
    Simons, K.
    Lennon, A. M.
    Wolfgang, C. L.
    Tomasetti, C.
    Papadopoulos, N.
    Kinzler, K. W.
    Vogelstein, B.
    Gibbs, P.
    ANNALS OF ONCOLOGY, 2019, 30 (09) : 1472 - 1478
  • [22] Circulating tumor DNA analysis for assessment of recurrence risk, benefit of adjuvant therapy, and early relapse detection after treatment in colorectal cancer patients.
    Henriksen, Tenna, V
    Tarazona, Noelia
    Reinert, Thomas
    Carbonell-Asins, Juan Antonio
    Renner, Derrick
    Sharma, Shruti
    Roda, Desamparados
    Huerta, Marisol
    Rosello, Susana
    Iversen, Lene H.
    Gotschalck, Kare Andersson
    Madsen, Anders Husted
    Andersen, Per Vadgaard
    Thorlacius-Ussing, Ole
    Love, Uffe S.
    Sethi, Himanshu
    Aleshin, Alexey
    Cervantes, Andres
    Andersen, Claus Lindbjerg
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [23] Could We Decide Adjuvant Therapy of Colon Cancer Based on Microarrays?
    Coyle, Vicky M.
    Allen, Wendy L.
    Johnston, Patrick G.
    CURRENT COLORECTAL CANCER REPORTS, 2007, 3 (03) : 137 - 142
  • [24] Sequencing of Tumor DNA to Guide Cancer Risk Assessment and Therapy
    Spencer, David H.
    Ley, Timothy J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (14): : 1497 - 1498
  • [25] Adjuvant therapy in high-risk colon cancer
    Bleiberg, H
    SEMINARS IN ONCOLOGY, 2000, 27 (05) : 48 - 59
  • [26] Circulating tumor DNA analysis: potential to revise adjuvant therapy for stage II colorectal cancer
    Zhu, Ning
    Hu, Hanguang
    Yuan, Ying
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [27] Circulating tumor DNA analysis: potential to revise adjuvant therapy for stage II colorectal cancer
    Ning Zhu
    Hanguang Hu
    Ying Yuan
    Signal Transduction and Targeted Therapy, 7
  • [28] Circulating tumor-specific DNA: A marker for monitoring efficacy of adjuvant therapy in cancer patients
    Fiegl, H
    Millinger, S
    Mueller-Holzner, E
    Marth, C
    Ensinger, C
    Berger, A
    Klocker, H
    Goebel, G
    Widschwendter, M
    CANCER RESEARCH, 2005, 65 (04) : 1141 - 1145
  • [29] Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA)
    Emily A. Verbus
    Alexander J. Rossi
    Allen J. Luna
    Atif Iqbal
    Van K. Morris
    Jonathan M. Hernandez
    Annals of Surgical Oncology, 2021, 28 : 4095 - 4097
  • [30] Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA)
    Verbus, Emily A.
    Rossi, Alexander J.
    Luna, Allen J.
    Iqbal, Atif
    Morris, Van K.
    Hernandez, Jonathan M.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (08) : 4095 - 4097
12345